Skip to main content
Top
Published in: NeuroMolecular Medicine 4/2021

01-12-2021 | Epilepsy | Original Paper

Gene Expression Analysis Identifies Cholesterol Metabolism Dysregulation in Hippocampus of Phenytoin-Resistant Pentylenetetrazol-Kindled Epileptic Mice

Authors: Sridhar Amalakanti, Unis Ahmad Bhat, Madhavi B. Mylavarapu, Nitin Khandelwal, N. V. Sundarachary, Sumana Chakravarty, Arvind Kumar

Published in: NeuroMolecular Medicine | Issue 4/2021

Login to get access

Abstract

Pharmaco-resistant Epilepsy has been a major challenge for medical interventions in controlling seizures. To date, up to 33% of the patients with epilepsy do not show adequate response to anti-epileptic drugs even after prolonged combinatorial drug usage. Using microarray, this study explores the changes in hippocampal gene expression in the phenytoin-resistant pentylenetetrazol (PTZ)-kindled mouse model of epilepsy. Our results from mRNA microarray analysis show distinct gene expression profiles in the hippocampus of phenytoin-resistant and sensitive mice. Pathway enrichment analysis showed differential expression of genes involved in cholesterol biosynthesis in phenytoin-resistant and sensitive mice.
Appendix
Available only for authorised users
Literature
go back to reference Alves, M., Gomez-Villafuertes, R., Delanty, N., Farrell, M. A., O’Brien, D. F., Miras-Portugal, M. T., et al. (2017). Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy. Epilepsia, 58(9), 1603–1614. https://doi.org/10.1111/epi.13850.CrossRefPubMed Alves, M., Gomez-Villafuertes, R., Delanty, N., Farrell, M. A., O’Brien, D. F., Miras-Portugal, M. T., et al. (2017). Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy. Epilepsia, 58(9), 1603–1614. https://​doi.​org/​10.​1111/​epi.​13850.CrossRefPubMed
go back to reference Chali, F., Djelti, F., Eugene, E., Valderrama, M., Marquer, C., Aubourg, P., et al. (2015). Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus. European Journal of Neuroscience, 41(10), 1345–1355. https://doi.org/10.1111/ejn.12911.CrossRef Chali, F., Djelti, F., Eugene, E., Valderrama, M., Marquer, C., Aubourg, P., et al. (2015). Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus. European Journal of Neuroscience, 41(10), 1345–1355. https://​doi.​org/​10.​1111/​ejn.​12911.CrossRef
Metadata
Title
Gene Expression Analysis Identifies Cholesterol Metabolism Dysregulation in Hippocampus of Phenytoin-Resistant Pentylenetetrazol-Kindled Epileptic Mice
Authors
Sridhar Amalakanti
Unis Ahmad Bhat
Madhavi B. Mylavarapu
Nitin Khandelwal
N. V. Sundarachary
Sumana Chakravarty
Arvind Kumar
Publication date
01-12-2021
Publisher
Springer US
Published in
NeuroMolecular Medicine / Issue 4/2021
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-021-08648-0

Other articles of this Issue 4/2021

NeuroMolecular Medicine 4/2021 Go to the issue